Therefore, L-APP detected by proseqff178928 could be used as a blood biomarker for Alzheimer's disease and as a biomarker for therapeutic efficacy since it is derived from astrocytes as well as GFAP and is detected more frequently in SAD than in NCI. The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.